New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Extraction and Purification of Delta-9-THC For Use in MedChew RX Clinical Program
19 juin 2018 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the United States...
AXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS Patients
23 janv. 2018 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), the world leader in cannabinoid research and development, announced today that it has successfully completed an...
AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard
13 avr. 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Dr. Ilya Reznik, a...
New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products
16 nov. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Nov. 16, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in hemp cannabinoid research and development, today announced that the United...
AXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart for Pharmaceutical Clinical Trials Program in Cannabinoid R&D
03 nov. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Nov. 03, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has published a...
AXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple Indications
26 oct. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the Company has...
AXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa Pharmaceuticals
19 sept. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
RAFA to Distribute Axim’s Award-Winning Cannabinoid Chewing Gum CanChew®NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), an innovative biotechnology company...
AXIM Biotech Leads Cannabis Industry in Cannabinoid Research, Development and Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure
18 févr. 2016 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) shares the hemp innovator’s vision and...
AXIM Biotechnologies Featured in Marijuana Documentary “Cannabis is Medicine”
13 janv. 2016 09h15 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 13, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) is pleased to announce that the Company’s efforts on clinical development of a patented cannabinoid-based medical...
AXIM Biotechnologies Secures Land Down Payment for Hemp Life Sciences Manufacturing Site
30 oct. 2015 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Oct. 30, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce that it has secured the down payment on land to build the Company’s manufacturing...